Facial plast Surg 2004; 20(1): 77-83
DOI: 10.1055/s-2004-822963
Copyright © 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001 USA.

Use of the KTP Laser in the Treatment of Rosacea and Solar Lentigines

Benjamin A. Bassichis1 , Ravi Swamy2 , Steven H. Dayan3
  • 1University of Texas-Southwestern Medical Center; Division of Facial Plastic and Reconstructive Surgery, Veterans Administration Hospital, Dallas, TX
  • 2University of Chicago-Pritsker School of Medicine, Chicago, IL
  • 3Division of Facial Plastic Surgery, Department of Otolaryngology, University of Illinois, Chicago, IL
Further Information

Publication History

Publication Date:
22 March 2004 (online)

Numerous techniques have evolved in facial plastic surgery to treat rosacea and solar lentigines. The treatment regimens range from avoidance of causative factors to the use of topical agents or other modalities that target the superficial layers of the skin. Of the modalities that target the epidermis, lasers offer the physician and patient the ability to target specific chromophores in the skin. Advances in laser technology led to the implementation of targeting certain characteristic pigments of abnormal areas with minimal damage to surrounding normal tissue. Rosacea and solar lentigines have characteristic cells that are targeted by a potassium-titanyl-phosphate (KTP) laser. The lesions are different in their origins but share the ability to be treated successfully with the KTP laser. A review of both conditions and other treatment options is discussed.